XML 102 R84.htm IDEA: XBRL DOCUMENT v3.20.4
Schedule I Condensed Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Current assets:        
Cash and cash equivalents $ 16,921 $ 10,985 $ 10,866 $ 11,981
Total current assets 53,718 42,634    
Other assets 11,510 9,334    
Total assets 197,289 173,889 152,221  
Current liabilities:        
Accounts payable and accrued liabilities 22,495 19,005    
Short-term borrowings and current maturities of long-term debt 4,819 3,870    
Total current liabilities 72,420 61,782    
Long-term debt, less current maturities 38,648 36,808    
Other liabilities 12,315 10,144    
Total liabilities 126,750 111,727    
Commitments and contingencies (Note 4)    
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 946 and 948 issued and outstanding 10 9    
Additional paid-in capital 0 7    
Retained earnings 69,295 61,178    
Accumulated other comprehensive loss (3,814) (3,578)    
Total liabilities and shareholders’ equity 197,289 173,889    
Parent Company [Member]        
Current assets:        
Cash and cash equivalents 258 46 $ 434 $ 359
Other current assets 562 787    
Total current assets 820 833    
Equity in net assets of subsidiaries 107,714 93,467    
Long-term notes receivable from subsidiaries 5,021 5,079    
Other assets 342 794    
Total assets 113,897 100,173    
Current liabilities:        
Accounts payable and accrued liabilities 589 688    
Current portion of notes payable to subsidiaries 4,882 750    
Short-term borrowings and current maturities of long-term debt 4,465 3,548    
Total current liabilities 9,936 4,986    
Long-term debt, less current maturities 37,815 35,926    
Long-term notes payable to subsidiaries 0 1,314    
Other liabilities 655 331    
Total liabilities 48,406 42,557    
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 946 and 948 issued and outstanding 10 9    
Additional paid-in capital 0 7    
Retained earnings 69,295 61,178    
Accumulated other comprehensive loss (3,814) (3,578)    
Total UnitedHealth Group shareholders’ equity 65,491 57,616    
Total liabilities and shareholders’ equity $ 113,897 $ 100,173